Detalhe da pesquisa
1.
Pemigatinib for metastatic or surgically unresectable urothelial carcinoma with FGF/FGFR genomic alterations: final results from FIGHT-201.
Ann Oncol
; 35(2): 200-210, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37956738
2.
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1.
Ann Oncol
; 34(10): 920-933, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37704166
3.
Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysis.
Ann Oncol
; 34(2): 173-185, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36414192
4.
Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study.
Ann Oncol
; 33(9): 929-938, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35680043
5.
Health-related quality of life with pembrolizumab monotherapy in patients with previously treated advanced microsatellite instability high/mismatch repair deficient endometrial cancer in the KEYNOTE-158 study.
Gynecol Oncol
; 166(2): 245-253, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35835611
6.
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature.
Gynecol Oncol
; 162(1): 80-87, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33896588
7.
[Neonates exposure to parabens through medicines administered to inpatients]. / Exposition des nouveau-nés aux parabènes via les médicaments administrés durant leur hospitalisation.
Ann Pharm Fr
; 78(4): 343-350, 2020 Jul.
Artigo
em Francês
| MEDLINE | ID: mdl-32253021
8.
Reply to the Letter to the Editor "Importance of pain management in cancer patients and survivors" by K. Bhatt et al.
Ann Oncol
; 35(5): 475-476, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38311209
9.
Trastuzumab deruxtecan for breast cancer: do patients experience a comprehensive benefit?
Ann Oncol
; 34(7): 567-568, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37349024
10.
Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016.
Ann Oncol
; 29(12): 2288-2295, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30304498
11.
Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study.
Ann Oncol
; 28(3): 634-641, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27993793
12.
The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline.
Ann Oncol
; 33(9): 878-892, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35462007
13.
Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study.
Ann Oncol
; 28(12): 3009-3014, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045518
14.
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab.
Ann Oncol
; 27(4): 732-8, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26802161
15.
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy.
Ann Oncol
; 27(12): 2224-2229, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789469
16.
Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT).
Ann Oncol
; 27(10): 1947-53, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27502712
17.
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study.
Ann Oncol
; 26(4): 798-803, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25538176
18.
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial.
Ann Oncol
; 26(4): 675-682, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25488686
19.
Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy.
Br J Cancer
; 110(7): 1721-6, 2014 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-24619072
20.
Reply to the letter to the editor 'On the underreporting of health-related quality of life and regulatory approval' by Bhamidipati et al.
Ann Oncol
; 30(4): 658-659, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30698648